- Home
- NATR vs CMPX Comparison
NATR vs CMPX Comparison
Compare NATR & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NATR
- CMPX
- Stock Information
- Founded
- NATR 1972
- CMPX 2014
- Country
- NATR United States
- CMPX United States
- Employees
- NATR N/A
- CMPX N/A
- Industry
- NATR Biotechnology: Pharmaceutical Preparations
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- NATR Health Care
- CMPX Health Care
- Exchange
- NATR Nasdaq
- CMPX Nasdaq
- Market Cap
- NATR 271.6M
- CMPX 291.8M
- IPO Year
- NATR N/A
- CMPX N/A
- Fundamental
- Price
- NATR $16.54
- CMPX $2.97
- Analyst Decision
- NATR Strong Buy
- CMPX Strong Buy
- Analyst Count
- NATR 2
- CMPX 8
- Target Price
- NATR $20.50
- CMPX $13.50
- AVG Volume (30 Days)
- NATR 86.7K
- CMPX 1.3M
- Earning Date
- NATR 07-31-2025
- CMPX 08-11-2025
- Dividend Yield
- NATR N/A
- CMPX N/A
- EPS Growth
- NATR N/A
- CMPX N/A
- EPS
- NATR 0.75
- CMPX N/A
- Revenue
- NATR $460,818,000.00
- CMPX N/A
- Revenue This Year
- NATR $3.08
- CMPX N/A
- Revenue Next Year
- NATR $2.41
- CMPX N/A
- P/E Ratio
- NATR $22.09
- CMPX N/A
- Revenue Growth
- NATR 4.33
- CMPX N/A
- 52 Week Low
- NATR $11.01
- CMPX $1.15
- 52 Week High
- NATR $18.06
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- NATR 63.70
- CMPX 50.84
- Support Level
- NATR $15.16
- CMPX $2.66
- Resistance Level
- NATR $16.79
- CMPX $3.47
- Average True Range (ATR)
- NATR 0.55
- CMPX 0.25
- MACD
- NATR 0.16
- CMPX -0.02
- Stochastic Oscillator
- NATR 91.32
- CMPX 38.27
About NATR Nature's Sunshine Products Inc.
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.